JGC
CSII

J. Goldman & Co’s Cardiovascular Systems, Inc. CSII Stock Holding History

J. Goldman & Co’s Portfolio CSII Stock Details CSII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-147,111
Closed -$4.64M – 418
2020
Q2 		$4.64M Buy
+147,111
New +$5.49M 0.29% 105

Other funds holding CSII

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Granahan Investment Management
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

J. Goldman & Co's CSII Position: Q3 2020 in Review

J. Goldman & Co sold out of Cardiovascular Systems, Inc. (CSII) in Q3 2020, closing a stake of 147,111 shares — an estimated $4.64M sold.

J. Goldman & Co first reported a position in CSII in Q2 2020 and held it in 1 quarter. The position peaked at $4.64M in Q2 2020. 186 funds tracked by Wall St. Rank hold CSII as of Q3 2020.

  • J. Goldman & Co reported no remaining Cardiovascular Systems, Inc. position as of Q3 2020 after selling out during the quarter.
  • J. Goldman & Co sold 147,111 Cardiovascular Systems, Inc. shares in Q3 2020, an estimated $4.64M.
  • J. Goldman & Co first reported a position in Cardiovascular Systems, Inc. in Q2 2020 and held it in 1 quarter.
  • J. Goldman & Co's Cardiovascular Systems, Inc. position peaked at $4.64M in Q2 2020.
  • 186 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q3 2020.

Based on J. Goldman & Co's 13F filing for Q3 2020, filed 16 Nov 2020.